ID   LNCaP-OM
AC   CVCL_9U27
DR   cancercelllines; CVCL_9U27
DR   Wikidata; Q54902845
RX   PubMed=9112118;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; 644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0395 ! LNCaP
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 12
//
RX   PubMed=9112118; DOI=10.1007/s11626-997-0131-1;
RA   Platica M., Verma R.S., Macera M.J., Platica O.;
RT   "LNCaP-OM, a new androgen-resistant prostate cancer subline.";
RL   In Vitro Cell. Dev. Biol. Anim. 33:147-149(1997).
//